Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEPARATION: Protamine Dosing Strategies in Cardiovascular Surgery
NCT04628884Phase 4Unknown
- Sponsor
- Fundación Clínica Shaio
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of protamine in heparin-induced thrombocytopenia (HIT) (2 arms), sponsored by Fundación Clínica Shaio. Primary endpoint: Postoperative mediastinal bleeding at 24 hours. Status: unknown.
02
Drugs
protamine
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT04628884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04628884.